# Topical 0.4% Ketorolac and Vitreoretinal Surgery

> **NCT00576329** · PHASE2,PHASE3 · COMPLETED · sponsor: **Emory University** · enrollment: 76 (actual)

## Conditions studied

- Surgery

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT00576329
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576329, "Topical 0.4% Ketorolac and Vitreoretinal Surgery". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00576329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*